Pyrrole derivatives with CRTh2 receptor modulator activity

Details for Australian Patent Application No. 2007260297 (hide)

Owner Novartis AG

Inventors Pipet, Maude Nadine Pierrette; Sandham, David Andrew; Leblanc, Catherine; Bala, Kamlesh Jagdis; Adcock, Claire

Agent Davies Collison Cave

Pub. Number AU-A-2007260297

PCT Pub. Number WO2007/144127

Priority 0611695.8 13.06.06 GB

Filing date 11 June 2007

Wipo publication date 21 December 2007

International Classifications

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

8 January 2009 PCT application entered the National Phase

  PCT publication WO2007/144127 Priority application(s): WO2007/144127

8 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007260298-Pyrrolidine compounds as renin inhibitors

2007260296